LabCompass

Mateusz Opyrchal

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID
Cancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsAdvanced Breast Cancer TherapiesGenetic factors in colorectal cancer

Publications

218

Citations

2,855

Est. group size

—

Recurring co-author estimate

Active years

25

Publishing since 2002

Research summary
AI-generated

Mateusz Opyrchal studies cancer treatment, focusing on breast cancer and other solid tumors. Much of the work involves clinical trials of targeted drugs (such as CDK4/6 inhibitors and PARP inhibitors) and immunotherapies, along with identifying biomarkers that predict which patients will respond to these treatments. The research spans laboratory analysis, molecular characterization, and patient trials.

Breast cancer therapy and drug resistanceCancer immunotherapy and vaccinesPredictive biomarkers of treatment responseClinical trials of targeted drugsCirculating tumor DNA and molecular characterization

Publication activity grew over the decade, peaking sharply around 2023 and remaining at a high level, averaging roughly 24 publications per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 24.2/year recently
2017: 11 publications172018: 12 publications182019: 16 publications192020: 15 publications202021: 10 publications212022: 18 publications222023: 46 publications46232024: 27 publications242025: 20 publications252026: 10 publications26
Recent publications
Publishes in
  • Cancer Research×33
  • Journal of Clinical Oncology×21
  • Regular and Young Investigator Award Abstracts×7
  • Clinical Cancer Research×5
  • Breast Cancer Research and Treatment×5

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile